96303004: Lovastatin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\HMG-CoA reductase inhibitor (substance)\Lovastatin

\Drug or medicament (substance)\agent cardiovasculaire\Antilipemic agent (substance)\HMG-CoA reductase inhibitor (substance)\Lovastatin

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Hydrocarbon\Aromatic hydrocarbon\Polyaromatic hydrocarbon\Naphthalene\Lovastatin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lovastatin	Is a	Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin	Is a	HMG-CoA reductase inhibitor (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin	Is a	Naphthalene	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin	Has disposition	3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lovastatin 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely lovastatin 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing lovastatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 20 mg and nicotinic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing lovastatin and nicotinic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 10mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 20mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 40mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 60mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 40 mg and nicotinic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to lovastatin (finding)	Causative agent (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adverse reaction caused by lovastatin	Causative agent (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 20 mg and nicotinic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 20 mg and nicotinic acid 1 g oral tablet	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 40 mg and nicotinic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 40 mg and nicotinic acid 1 g oral tablet	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 10 mg oral tablet	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lovastatin 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lovastatin 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 40 mg oral tablet	Has basis of strength substance (attribute)	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet	Has basis of strength substance (attribute)	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 20mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 40mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 10mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 60mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lovastatin 10 mg oral tablet	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely lovastatin 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 40 mg oral tablet	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin 40 mg and nicotinic acid 1 g oral tablet	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin 20 mg and nicotinic acid 1 g oral tablet	Has precise active ingredient	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Lovastatin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Lovastatin- and nicotinic acid-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only lovastatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only lovastatin and nicotinic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only lovastatin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only lovastatin and nicotinic acid in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lovastatin	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
159404017	Lovastatin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
159405016	Mevinolin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
159406015	Monacolin K	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
840639018	Lovastatin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
159404017	Lovastatin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
159404017	Lovastatin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
159405016	Mevinolin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
159405016	Mevinolin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
159406015	Monacolin K	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
159406015	Monacolin K	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
840639018	Lovastatin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
840639018	Lovastatin (substance)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
840639018	Lovastatin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4736691000241119	lovastatine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
4736691000241119	lovastatine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module